Tianfulong and Jinjiang Electronics Receive Inquiry Notice for Shanghai Stock Exchange IPO

Intelligent Finance APP learned on July 7 that the IPO review status of Yangzhou Tianfulong Group Co., Ltd. and Sichuan Jinjiang Electronic Medical Device Technology Co., Ltd. applying to the Shanghai Stock Exchange has been changed to "Under Inquiry."

According to the prospectus, Tianfulong's main business is the research, production, and sales of differentiated polyester staple fibers. Its product lineup has expanded from recycled colored polyester staple fibers to differentiated composite fibers and polyester new materials, covering scenarios such as business, travel, home, healthcare, and clothing. The company’s recycled colored polyester staple fibers have a wide range of applications, primarily used in automotive interiors, flooring materials, home textiles, construction engineering, and footwear and apparel materials. According to statistics from the China Chemical Fibers Industry Association, from 2020 to 2022, the company ranked first in domestic sales for colored polyester staple fibers used in automotive interiors and low-melting-point staple fibers.

Jinjiang Electronic is an innovative enterprise that focuses on the research, development, production, and sales of high-end innovative medical devices for diagnosis and ablation in the field of cardiac electrophysiology. The quality and performance of its core products fully match those of international leaders. With over two decades of experience in the cardiac electrophysiology field, the company is a pioneer in China's cardiac electrophysiology industry. As of April 30, 2023, the company has obtained 13 Class III medical device product registration certificates, 4 Class II medical device product registration certificates, and CE certification for 3 products in the European Union. The company’s core R&D products, the LEAD-PFA® Cardiac Pulse Field Ablation Instrument and the PulsedFA® Single-Use Cardiac Pulse Field Ablation Catheter, entered the Special Review Procedure for Innovative Medical Devices (Green Channel) in June 2022. Their product registration applications have been officially accepted by the NMPA, advancing ahead of domestic and international competitors, with an expected market launch in the fourth quarter of 2023.